Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100120190260040213
´ëÇÑ°ñ´ë»çÇÐȸÁö
2019 Volume.26 No. 4 p.213 ~ p.224
Position Statement on the Use of Bone Turnover Markers for Osteoporosis Treatment
Park So-Young

Ahn Seong-Hee
Yoo Jun-Il
Chung Youn-Jee
Jeon Yun-Kyung
Yoon Byung-Ho
Kim Ha-Young
Lee Seung-Hun
Lee Je-Hoon
Hong Seong-Bin
Abstract
Current evidences continue to support the clinical application of bone turnover markers (BTMs) in the management of postmenopausal osteoporosis. The limitations of bone mineral density measured by dual energy X-ray absorptiomet especially emphasize the beneficial roles of BTMs, such as serum C-terminal telopeptide of type I collagen and serum procollagen type I N-propeptide, as monitoring tools to assess the responses to treatment. Therefore, the proper application and assessment of BTM in clinical practice is very important. However, their use in Korea is still insufficient. Therefore, the BTM committee has set up by the Korean Society for Bone and Mineral Research have been constituted and provided a position statement which will suggest on the clinical application of BTM for the management of postmenopausal osteoporosis in Korea.
KEYWORD
Bone remodeling, Osteoporosis, Republic of Korea
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed